Adverse
effects
The overall incidence of adverse
effects in clinical trials lies between 3 and 4%. Gastrointestinal
troubles (nausea, abdominal pain, vomiting), dermatologic
reactions (rash, urticaria), and respiratory disorders
(coughing, dyspnea, asthma), as well as generalized problems
(fever, fatigue, allergic reactions) are the most frequent
complaints reported.
In case of lasting gastrointestinal disorders, treatment
should be interrupted.
In case of long-lasting skin reactions and respiratory
problems, the treatment should be interrupted as these
may constitute allergic reactions. |
|
